Activites

• 2003/06/25 Final act published in Official Journal
  • Directive 2003/36
  • OJ L 156 25.06.2003, p. 0026-0030
• 2003/05/26 Final act signed
• 2003/05/26 End of procedure in Parliament
• 2003/04/10 Debate in Parliament
  • Debate in Parliament
  • T5-0180/2003 summary

    The European Parliament adopted the resolution by Inger SCH·RLING (Greens/EFA, S) approving the Council's common position without amendment.�

• 2003/03/25 Vote in committee, 2nd reading
  • A5-0099/2003
• 2003/01/30 Committee referral announced in Parliament, 2nd reading
• #2480
• 2003/01/21 Council Meeting
  • 15703/2/2002 summary

    The Council has been examining the proposal since spring 2002. The Council's common position is in substance identical to the Commission's proposal. As concerns amendment 5, 3 and 6, second part, the Council, in general, shares the concern of the European Parliament in relation to CMR substances in articles/products. However, the Council cannot agree to an extension of the scope of application of the Directive as proposed by the parliament without basing it on scientific evaluation or a risk assessment. According to the current legislative framework; it is for the Member States and the Commission to determine, on the basis of risk assessment, whether substances and preparations and articles containing them pose a risk to public health or the environment. In this respect, it should be recalled that a very high number of CMR substances exist and that these are contained in an indefinite number of products. A product based approach to CMR substances would this, under the current legislative framework, be impossible to apply in practice. Furthermore, the Council considers that the proposed restrictions on certain CMR substances and preparations containing them provide adequate measures to limit the use of those CMR substances, and that these measures should be adopted without delay. Consequently, the Council cannot endorse these amendments by the Parliament and has rejected them. It should be noted that the issue of chemicals in products will be addressed in the context of the development of a new chemicals policy. It is the view of the Council that the envisaged measures in the new chemicals policy will considerably improve the effectiveness of the management of risks relating to dangerous substances, including CMR substances in articles. Finally, the Council agrees with the aim of the Parliament of ensuring that the CMR substances restricted under the Dangerous Substances Directive should be subject to the same restrictions in cosmetic products. However, the Council is of the opinion that CMR substances in cosmetics should be dealt with in the framework of the Cosmetics Directive (Directive 76/768/EEC) and therefore cannot accept the amendments proposed by the Parliament. �

• #2451
• 2002/09/30 Council Meeting
  • 2451
• 2002/06/11 Decision by Parliament, 1st reading/single reading
  • T5-0284/2002 summary

    Using its procedure without debate, the European Parliament adopted a resolution drafted by Inger SCHORLING (Greens, EFA, Sweden) on substances classified as carcinogens, mutagens or substances toxic to reproduction. (Please refer to the document dated 23/05/02.) The Commission is required to submit a proposal by the end of 2002 to phase out the use of such substances in articles for use by the general public.�

• 2002/05/23 Vote in committee, 1st reading/single reading
  • A5-0181/2002
• 2002/02/27 Committee referral announced in Parliament, 1st reading/single reading
• 2002/02/12 Legislative proposal published
  • COM(2002)0070 summary

    PURPOSE: To include an updated list of carcinogens, mutagens and substances toxic to reproduction (c/m/r) to Community legislation relating to the marketing and use thereof. CONTENT: Commission Directive 67/548/EEC deals with the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. An Annex attached to this Directive lists all the c/m/r substances banned for use in the EU. It is updated on a regular basis depending on technical progress. It was last amended in 2001 for the twenty-eighth time. Added to the Annex were: - two new substances newly classified as carcinogenic (category 1), - nineteen substances newly classified as carcinogenic (category 2), - five substances newly classified as mutagenic (category 2), - one substance newly classified as toxic to reproduction (category 1), and - sixteen substances newly classified as toxic to reproduction (category 2). Complementing Directive 67/548/EEC is Directive 76/769/EEC on the approximation of the laws regulations and administrative provision of the Member States relating to restriction on the marketing and use of certain dangerous substances and preparations. The aim of this Directive is to establish uniform rules for the circulation of substances and preparations classified as c/m/r. The purpose of the present Commission proposal is to update Directive 76/769/EEC in line with the amendments to Directive 67/548/EEC. In other words incorporating the newly labelled substances outlined above into the Annex of Directive 76/769/EEC. The estimated costs are low due to their limited use by the general public.�

  • DG [{'url': 'http://ec.europa.eu/enterprise/', 'title': 'Enterprise and Industry'}],

Documents

• Legislative proposal published: COM(2002)0070
• Committee report tabled for plenary, 1st reading/single reading: A5-0181/2002
• Decision by Parliament, 1st reading/single reading: T5-0284/2002
• Debate in Council: 2451
• Council position published: 15703/2/2002
• Committee recommendation tabled for plenary, 2nd reading: A5-0099/2003
• Debate in Parliament: Debate in Parliament
• Decision by Parliament, 2nd reading: T5-0180/2003
• : Directive 2003/36
• : OJ L 156 25.06.2003, p. 0026-0030

History

(these mark the time of scraping, not the official date of the change)